High burden of adverse events is associated with reduced remission rates in early rheumatoid arthritis

Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial

Catriona Grigor, Hilary A. Capell, A. Stirling et al. · The Lancet · 2004 · 1.4K citations

Medicine, Clinical Sciences, Internal Medicine +5

Early suppression of disease activity is essential for maintenance of work capacity in patients with recent‐onset rheumatoid arthritis: Five‐year experience from the FIN‐RACo trial

Kari Puolakka, Hannu Kautiainen, Timo Möttönen et al. · Arthritis & Rheumatism · 2005 · 231 citations

Medicine, Chronic Disease Control, Autoimmunity +14

The rheumatoid arthritis patient in the clinic: comparing more than 1300 consecutive DMARD courses

D Aletaha · British journal of rheumatology · 2002 · 227 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study

Faith Matcham, Sheila Ali, Katherine Irving et al. · BMC Musculoskeletal Disorders · 2016 · 112 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)

Marjatta Leirisalo‐Repo, Hannu Kautiainen, Leena Laasonen et al. · Annals of the Rheumatic Diseases · 2012 · 96 citations

Medicine, Internal Medicine, Pharmacotherapy +13